Beta Bionics (BBNX) Gains from Investment Securities (2024 - 2025)
Beta Bionics (BBNX) posted Gains from Investment Securities of $12.4 million for Q1 2025, up 106.74% sequentially from $6.0 million in Q4 2024, and up 200.8% YoY from $4.1 million in Q1 2024.
Beta Bionics (BBNX) Gains from Investment Securities (2024 - 2025) Analysis & Trends
Beta Bionics has reported Gains from Investment Securities for 2 years, with the latest figure at $12.4 million in Q1 2025.
- Quarterly Gains from Investment Securities rose 200.8% year-over-year to $12.4 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $12.4 million (down 7.17% YoY) and the FY2025 annual result came in at $12.4 million, down 7.17% from the prior year.
- Gains from Investment Securities grew to $12.4 million in Q1 2025 per BBNX's latest filing, from $6.0 million in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $12.4 million in Q1 2025 and troughed at -$419000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Beta Bionics | 853.71 Mn | 673.22 Mn | 18.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 12.45 Mn |
| Mar 31, 2025 | 12.45 Mn |
| Dec 31, 2024 | 6.02 Mn |
| Dec 31, 2024 | 6.02 Mn |
| Sep 30, 2024 | -419,000.00 |
| Sep 30, 2024 | -419,000.00 |
| Jun 30, 2024 | 3.67 Mn |
| Jun 30, 2024 | 3.67 Mn |
| Mar 31, 2024 | 4.14 Mn |
| Mar 31, 2024 | 4.14 Mn |